OverviewChartNewsTraderScreen

UniCredit Bonus Zert BAYN 31.12.2.../  DE000HD5S4T0  /

Frankfurt Zert./HVB
7/5/2024  7:37:04 PM Chg.+0.070 Bid9:59:16 PM Ask9:59:16 PM Underlying Strike price Expiration date Option type
19.570EUR +0.36% 19.570
Bid Size: 3,000		 19.600
Ask Size: 3,000		 BAYER AG NA O.N. 23.00 - 12/31/2024 Put
GlobeNewswire 6/25 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial
GlobeNewswire 5/30 Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire 5/30 BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire 5/29 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
GlobeNewswire 5/28 Pairwise and Bayer Expand CRISPR Leafy Greens Market through Licensing Agreement
TeleTrader 5/14 Bayer's sales in Q1 at €13.7 billion, down 4.3%
GlobeNewswire 5/2 AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...
GlobeNewswire 4/18 AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...
GlobeNewswire 4/16 AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire 4/11 Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire 4/9 AskBio Names Mansuo Shannon Chief Scientific Officer
GlobeNewswire 3/25 BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...
GlobeNewswire 3/14 Bayer and Aignostics to collaborate on next generation precision oncology
GlobeNewswire 3/6 BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...
TeleTrader 3/5 Bayer's Q4 sales at €11.9 billion
GlobeNewswire 3/4 BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
TeleTrader 3/4 Earnings preview: Bayer, Broadcom among those in calendar
GlobeNewswire 2/15 2Blades Delivers on Project with Bayer Crop Science to Combat Asian Soybean Rust
GlobeNewswire 2/13 Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...
GlobeNewswire 2/13 First patient randomized in AskBio Phase II gene therapy trial for congestive heart failure
TeleTrader 1/29 Bayer down over 5% after latest $2.25B Roundup ruling
TeleTrader 1/17 Bayer to cut jobs amid 'difficult situation'
GlobeNewswire 1/5 AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF)
GlobeNewswire 1/4 AskBio Phase Ib trial of AB-1005 gene therapy in patients with Parkinson’s disease meets primary end...
GlobeNewswire 12/14/2023 Iktos and Bayer Announce Collaboration to expand the use of Artificial Intelligence to Design New Su...